Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.22.2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 12,454 $ 8,274
Employee compensation and benefits 5,484 6,344
Professional fees 2,511 953
Facilities and other 30 53
Accrued expenses $ 20,479 $ 15,624